What is the evidence behind the capacity issues we have in systemic cancer treatment services in the UK?We know that SACT/chemotherapy services are struggling in the UK - what are the measures behind this? What has been tried to address is, and were they successful? Thank you!
Notes about answers
If you see something you feel is wrong, don’t criticise (that misses the point of Triple) courteously and supportively give a counter answer.
Answers given should be in good faith, but they should not be considered definitive, be critical.
We do not endorse or verify content posted by users.
Thanks for your response,
Thanks for your question,